Local view for "http://purl.org/linkedpolitics/eu/plenary/2011-02-16-Speech-3-222-000"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2011-02-16"^^xsd:date2
dcterms:Is Part Of	lp_eu:Explanations of vote2
dcterms:Language	"en"^^xsd:language2
lpv:document identification number	"en.20110216.11.3-222-000"2
lpv:hasSubsequent	lp_eu:2011-02-16-Speech-3-223-0002
lpv:speaker	lp:David Martin2
lpv:spoken text	". Counterfeit medicines are already widespread in the developing world where 20-30% of medicines on the market are fake. They are now being found increasingly in the EU. Around 1% of medicines sold in Europe are estimated counterfeit. This new agreement, which I welcome, will introduce mandatory safety features, such as seals and serial numbers for prescription medicines. This will allow for their traceability. Generics will not be included in the requirements unless a certain product is at exceptional risk of being counterfeited."@en1
lpv:spokenAs	member; Delegation for relations with the Korean Peninsula (2009-09-17--2014-06-30)3 member; AFCO (2010-03-10--2012-01-18)3 member; INTA (2009-07-16--2012-01-18)3 member; Delegation to the ACP-EU Joint Parliamentary Assembly (2009-09-16--2014-06-30)3 chair; Delegation to the Cariforum — EU Parliamentary Committee (2010-09-08--2014-06-30)3 unknown; Labour Party (2009-07-14--2014-06-30)3 member; S&D (2009-07-14--2014-06-30)3 member; Conference of Delegation Chairs (2010-09-08--2014-06-30)3 member; DROI (2009-07-16--2012-01-18)3
lpv:unclassifiedMetadata	"David Martin (S&D ),"1 "in writing"1

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph